New Report: At 7.0% CAGR, 3D Printed Drugs Market Size, Growth Analysis to accrue USD 437.04 million by 2025
The MarketWatch News Department was not involved in the creation of this content.
Sep 15, 2020 (Heraldkeepers) —
3D Printed Drugs market is valued at USD 272.17 million in 2018 and expected to reach USD 437.04 million by 2025 with a CAGR of 7.0% over the forecast period.
Key Players –
Some major key players for global 3D Printed Drugs market are 3D Printer Drug Machine, Aprecia Pharmaceuticals, Hewlett Packard Caribe, BV, LLC, GlaxoSmithKline Plc., FabRx Ltd., Cycle Pharmaceuticals and others.
Get Sample of This Report@https://brandessenceresearch.com/requestSample/PostId/432
Market Analysis of 3D Printed Drugs –
3D printed drugs are medications, which are designed by 3D printing technique to modify for individuals in a safe and effective way. 3D printed drugs are developed by using powder-liquid three dimensional printing technologies. This technique uses an aqueous fluid which is able to bind different or similar layer of powders and produces multiple types of